0001237899-12-000087.txt : 20121127 0001237899-12-000087.hdr.sgml : 20121127 20121127175403 ACCESSION NUMBER: 0001237899-12-000087 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20121126 FILED AS OF DATE: 20121127 DATE AS OF CHANGE: 20121127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER CHARLES A CENTRAL INDEX KEY: 0001225470 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 121227377 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER RD CITY: TARRYTOWN STATE: NY ZIP: 10591-6707 BUSINESS PHONE: 9143477000 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2012-11-26 0 0000872589 REGENERON PHARMACEUTICALS INC REGN 0001225470 BAKER CHARLES A 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 1 0 0 0 Common Stock 2012-11-26 4 M 0 1100.0 9.17 A 10690.0 D Common Stock 2012-11-26 4 S 0 1100.0 175.14 D 9590.0 D Common Stock 2012-11-26 4 M 0 6565.0 9.17 A 16155.0 D Common Stock 2012-11-26 4 S 0 6565.0 174.46 D 9590.0 D Common Stock 2012-11-26 4 M 0 5035.0 9.17 A 14625.0 D Common Stock 2012-11-26 4 S 0 5035.0 173.63 D 9590.0 D Common Stock 2012-11-26 4 M 0 1200.0 9.17 A 10790.0 D Common Stock 2012-11-26 4 S 0 1200.0 172.65 D 9590.0 D Common Stock 2012-11-26 4 M 0 1100.0 9.17 A 10690.0 D Common Stock 2012-11-26 4 S 0 1100.0 171.45 D 9590.0 D Non-Qualified Stock Option (right to buy) 9.17 2012-11-26 4 M 0 1100.0 D 2015-01-03 Common Stock 1100.0 13900.0 D Non-Qualified Stock Option (right to buy) 9.17 2012-11-26 4 M 0 6565.0 D 2015-01-03 Common Stock 6565.0 7335.0 D Non-Qualified Stock Option (right to buy) 9.17 2012-11-26 4 M 0 5035.0 D 2015-01-03 Common Stock 5035.0 2300.0 D Non-Qualified Stock Option (right to buy) 9.17 2012-11-26 4 M 0 1200.0 D 2015-01-03 Common Stock 1200.0 1100.0 D Non-Qualified Stock Option (right to buy) 9.17 2012-11-26 4 M 0 1100.0 D 2015-01-03 Common Stock 1100.0 0.0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $175.00 to $175.55. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price. Represents volume-weighted average price of sales of 6,565 shares of Company stock on November 26, 2012 at prices ranging from $174.07 to $174.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price. Represents volume-weighted average price of sales of 5,035 shares of Company stock on November 26, 2012 at prices ranging from $173.08 to $173.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price. Represents volume-weighted average price of sales of 1,200 shares of Company stock on November 26, 2012 at prices ranging from $172.06 to $172.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price. Represents volume-weighted average price of sales of 1,100 shares of Company stock on November 26, 2012 at prices ranging from $171.01 to $171.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 26, 2012 at each separate price. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case. /s/**Charles A. Baker 2012-11-27